2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Sep 12, 2025.
The trade is 4.8% of the 2,279,453 shares held after it.
No other insider sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Fitzpatrick Jonathan G. sold about $2.0M of DRVN on Sep 15, 2025, the largest insider sale at the company since 2022; 111 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 30, 2023.
The trade is 3.1% of the 2,389,453 shares held after it.
No other insider sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Fitzpatrick Jonathan G. sold about $1.4M of DRVN on Sep 12, 2025, the largest insider sale at the company since 2022; 111 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 23.8% of the 17,791 shares held after it.
No other insider sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Halligan Catherine Ann sold about $73.9K of DRVN on Mar 3, 2025, the largest insider sale at the company since 2022; 111 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 1.8% of the 2,332,363 shares held after it.
1 other insider bought within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Fitzpatrick Jonathan G. bought about $997.9K of DRVN on May 30, 2023, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 111 funds added in the latest 13F quarter.
25 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
DRVN planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
DRVN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
BARON SMALL CAP FUND
$62.7M position · as of 2026-06-30
2.2%
Fidelity Advisor Value Fund
$3.0M position · as of 2026-07-31
0.7%
Fidelity Value Fund
$77.6M position · as of 2026-07-31
0.7%
VIP Value Strategies Portfolio
$8.1M position · as of 2026-06-30
0.7%
Fidelity Advisor Value Strategies Fund
$14.2M position · as of 2026-05-31
0.6%
VIP Value Portfolio
$4.1M position · as of 2026-06-30
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Jonathan Fitzpatrick
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$7.7M
$11.6M
$3.1M
-39%
+53%
2023
$29.1M
$20.1M
$4.7M
-47%
+13%
2022
$6.8M
$3.1M
$2.1M
+2%
-21%
2021
$14.8M
$20.2M
$4.1M
+25%
+20%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 111 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM DRVN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
$2.3B
FY Dec 2022
$2.0B
FY Dec 2021
$1.5B
Jun 2026
$507.4M
Mar 2026
$484.4M
Dec 2025
$460.1M
Sep 2025
$535.7M
Jun 2025
$551.0M
Mar 2025
$516.2M
Dec 2024
$427.2M
Sep 2024
$591.7M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM DRVN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
-32.3%
FY Dec 2022
+2.1%
FY Dec 2021
+0.7%
Jun 2026
+6.7%
Mar 2026
+11.3%
Dec 2025
+4.6%
Sep 2025
+10.3%
Jun 2025
+9.8%
Mar 2025
+1.9%
Dec 2024
-71.8%
Sep 2024
-2.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$133.8M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM DRVN
FY Dec 2025
$107.8M
FY Dec 2024
-$44.7M
FY Dec 2023
-$367.9M
FY Dec 2022
-$239.0M
FY Dec 2021
$123.1M
Jun 2026
$28.9M
Mar 2026
$23.1M
Dec 2025
$36.2M
Sep 2025
$45.7M
Jun 2025
$17.4M
Mar 2025
$8.6M
Dec 2024
-$29.1M
Sep 2024
$38.7M
At each fiscal year end
Single quarter
Debt to equity
2.02x
long-term 2026-06-27 plus current 2026-06-27; equity 2026-06-27
Debt to equity DRVN
FY Dec 2025
2.81x
FY Dec 2024
4.95x
FY Dec 2023
3.25x
FY Dec 2022
1.66x
FY Dec 2021
1.45x
Jun 2026
2.02x
Mar 2026
2.12x
Dec 2025
2.81x
Sep 2025
3.03x
Jun 2025
3.48x
Mar 2025
4.56x
Dec 2024
4.95x
Sep 2024
3.15x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.19x
TTM operating cash flow over long-term 2026-06-27 plus current 2026-06-27
Cash flow to debt DRVN
FY Dec 2025
0.15x
FY Dec 2024
0.09x
FY Dec 2023
0.08x
FY Dec 2022
0.07x
FY Dec 2021
0.12x
Jun 2026
0.19x
Mar 2026
0.18x
Dec 2025
0.15x
Sep 2025
0.12x
Jun 2025
0.12x
Mar 2025
0.10x
Dec 2024
0.09x
Sep 2024
0.08x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity DRVN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
-58.2%
FY Dec 2022
+2.6%
FY Dec 2021
+0.7%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+0.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets DRVN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
-12.0%
FY Dec 2022
+0.7%
FY Dec 2021
+0.2%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+0.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital DRVN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed DRVN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
+2.0%
FY Dec 2022
+3.5%
FY Dec 2021
+3.6%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+19.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
11.69x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-29 to 2026-06-27
P/E, trailing DRVN
FY Dec 2025
17.44x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
109.24x
FY Dec 2021
832.50x
Jun 2026
14.07x
Mar 2026
11.25x
Dec 2025
17.44x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.4B
market value at close 2026-10-26 on 2026-08-04 shares, plus long-term 2026-06-27 plus current 2026-06-27, minus cash 2026-06-27
Enterprise value DRVN
FY Dec 2025
$4.5B
FY Dec 2024
$5.3B
FY Dec 2023
$5.1B
FY Dec 2022
$7.2B
FY Dec 2021
$7.4B
Jun 2026
$3.8B
Mar 2026
$3.6B
Dec 2025
$4.5B
Sep 2025
$4.8B
Jun 2025
$5.1B
Mar 2025
$5.5B
Dec 2024
$5.3B
Sep 2024
$5.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield DRVN
FY Dec 2025
+4.4%
FY Dec 2024
-1.7%
FY Dec 2023
-15.7%
FY Dec 2022
-5.2%
FY Dec 2021
+2.2%
Jun 2026
+5.8%
Mar 2026
+5.9%
Dec 2025
+4.4%
Sep 2025
+1.6%
Jun 2025
+1.2%
Mar 2025
-0.2%
Dec 2024
-1.7%
Sep 2024
-4.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing DRVN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.21x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
DRVN ranks highest on institutional and government (55th percentile) and growth (53rd), and lowest on financial health (30th), among Services peers.
Financial health
30
Inputs
Debt to equity2.02x · 14 pct, sector of 228
Cash flow to debt0.19x · 46 pct, sector of 199
Growth
53
Inputs
Revenue growth, YoY+6.3% · 53 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
55
Inputs
Funds adding, latest quarter111 · 55 pct, sector of 243
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
36
Inputs
Short interest, % of float+6.8% · 28 pct, sector of 384
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.3% · 43 pct, sector of 227
3 not measured: Profitability, Insider conviction, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of operating income; the filed year and its quarters do not reconcile, so the trailing figure is withheld
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.